Evidence map›Paper›PMID 22496237›Full record

ArticleJournal of virology2012

CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.

Douglas S Kwon, Mathieu Angin, Tomoyuki Hongo, Kenneth M Law, Jessica Johnson, Filippos Porichis, Meghan G Hart, David F Pavlik, Daniel P Tighe, Daniel G Kavanagh and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Animal models for viral infection and cell exhaustion.Current opinion in HIV and AIDS · 2014
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Douglas S KwonRagon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA.
Mathieu Angin
Tomoyuki Hongo
Kenneth M Law
Jessica Johnson
Filippos Porichis
Meghan G Hart
David F Pavlik
Daniel P Tighe
Daniel G Kavanagh
Hendrik Streeck
Marylyn M Addo
Daniel E Kaufmann
Ragon Institute of MGH, MIT and Harvard · USMassachusetts General Hospital · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Daniel Lingwood · 2004 to 2026
$94.4M
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunctionP01AI080192 · NIAID · EMORY UNIVERSITY · PI FREEMAN, GORDON JAMES · 2008 to 2012
$12.6M
Immunoregulatory networks and HIV pathogenesisR01HL092565 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KAUFMANN, DANIEL E · 2007 to 2015
$3.4M
T cell regulation: CD4+CD25+ FOXP3+ T cells in acute and chronic HIV-1 infectionK08AI074405 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ADDO, MARYLYN MARTINA · 2007 to 2010
$610k
Gut mucosal immunity to HIV-1 in controlled and progressive infectionK08AI084546 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KWON, DOUGLAS · 2009 to 2012
$498k
Development of needle-free, vectorless, RNA-based vaccines for HIVR21AI083133 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAVANAGH, DANIEL GARRETT · 2009 to 2010
$470k
HLA restriction and TCR affinity in HIVR56AI095088 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAVANAGH, DANIEL GARRETT · 2011 to 2011
$439k
NHLBI NIH HHS R01 HL092565NIAID NIH HHS 1K08 AI084546-01NIAID NIH HHS K08 AI074405NIAID NIH HHS K08 AI084546NIAID NIH HHS NIH P30 AI060354NIAID NIH HHS P01 AI080192NIAID NIH HHS P01AI-080192NIAID NIH HHS P30 AI060354NIAID NIH HHS R21 AI083133NIAID NIH HHS R56 AI095088
6 · The paper itself

Abstract

T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN-γ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN-γ secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14(+) monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.

Indexed as

Up-RegulationCD4-Positive T-LymphocytesHIV-1HIV InfectionsHumansInterferon-gammaInterleukin-10Interleukin-2 Receptor alpha SubunitLeukocytes, MononuclearMonocytesT-Lymphocytes, RegulatoryInterferon-gammaInterleukin-10Interleukin-2 Receptor alpha Subunit

Identifiers

PMID22496237
PMCPMC3393541
OpenAlexW2096635836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.